Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 25;42(2):16188.
doi: 10.36141/svdld.v42i2.16188.

Non-Invasive Procedure in Differential Diagnosis of Sarcoidosis and Tuberculosis Lymph Nodes: Radiomic Model of 18F-FDG PET-CT

Damla Serçe Unat  1 , Nursin Aguloglu  2 , Omer Selim Unat  3 , Aysegul Aksu  4 , Onur Fevzi Erer  3 , Ozer Ozdemir  3 , Gulru Polat  3
Affiliations

Non-Invasive Procedure in Differential Diagnosis of Sarcoidosis and Tuberculosis Lymph Nodes: Radiomic Model of 18F-FDG PET-CT

Damla Serçe Unat et al. Sarcoidosis Vasc Diffuse Lung Dis. .

Abstract

Background and aim: Clinical and pathological features of two granulomatous diseases tuberculosis (TB) and sarcoidosis lymphadenopathy share similar properties. 18-F FDG Positron-Emission Tomography-Computed Tomography (18F-FDG PET-CT) is performed to discriminate two diseases. Even biopsy and culture via Endobronchial Ultrasonography (EBUS) sometimes did not get definite diagnosis. Radiomics can defined as high-throughput mining of radiological images. We aimed to investigate the role of radiomic analysis of these 18F-FDG PET/CT images in discrimination of TB and sarcoidosis Methods: All patients with mediastinal LAP who underwent EBUS biopsy were screened for inclusion. Among these patients, patients who were diagnosed with TB or sarcoidosis by pathological and microbiological methods were included in the study. Radiomic model and clinicoradiomic models were formed AUC, sensitivity and specificity values of models obtained by logistic regression results were calculated.

Results: 54 tuberculosis and 163 sarcoidosis lymph nodes were analyzed. Gender, GLCM_Correlation and GLCM_Energy features were found to be important prognostic factors in distinguishing between sarcoidosis and tuberculosis (p: 0.012, OR: 2.423 (1.215-4.830, 95% CI); p<0.001, OR: 5.400 (2.108-13.830, 95%) CI); p<0.001, OR: 3.335 (1.693-6.571, 95% CI; respectively). The p, AUC, sensitivity, and specificity values of the obtained clinicoradiomic model were calculated as <0.001, 0.762 (0.651-0.798, 95% CI), 59.5% and 81.5%, respectively.

Conclusions: The model created with radiomics methods and clinical features gave significant results in distinguishing tuberculosis and sarcoidosis. This is promising for radiomic models that could replace invasive methods. It is expected that radiomic models will be used more in daily life in the future.

PubMed Disclaimer

Conflict of interest statement

Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.

Figures

Figure 1.
Figure 1.
Identification of the patient population.
Figure 2.
Figure 2.
ROC curves of the models, radiomic model AUC: 0.724, clinicoradiomic model AUC: 0.761.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Geneva: World Health organization; 2022. Global tuberculosis report 2022. licence: cc bY-Nc-sa 3.0 iGo.
    1. Visca D, Ong CWM, Tiberi S, et al. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021 Mar;27(2):151–65. - PMC - PubMed
    1. Jonas DE, Riley SR, Lee LC, et al. Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023 May;329(17):1495–509. - PubMed
    1. Keijsers RGM, Grutters JC. In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? J Clin Med 2020. 2020 Mar;9(3):890. - PMC - PubMed
    1. Belperio JA, Shaikh F, Abtin FG, et al. Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review. JAMA. 2022 Mar;327(9):856–67. - PubMed

LinkOut - more resources